7.29
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - marketscreener.com
A 10th annual growth conference is set for New York, with OptimizeRx taking part. - Stock Titan
Optimizerx Stock Price Forecast. Should You Buy OPRX? - StockInvest.us
OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.ca
OptimizeRx (OPRX) insider stock withheld for taxes - Stock Titan
OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com Canada
OptimizeRx appoints Troy Sarich as company advisor - Investing.com
OptimizeRx Appoints Former Johnson & Johnson Executive Troy Sarich as Company Advisor - quiverquant.com
Johnson & Johnson’s former data chief joins OptimizeRx to guide AI tools - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding - Stock Titan
OptimizeRx (NASDAQ: OPRX) reports new insider share transaction - Stock Titan
OPRX | OptimizeRx Corporation Common Stock FinancialsRevenue Breakdown - quiverquant.com
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript - AOL.com
OptimizeRx Corp (OPRX) Stock News Today - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
OptimizeRx (OPRX) Slips to $8.72 as Shares Consolidate Near Range MidpointInverse ETF Flow - vinanet.vn
OptimizeRx Corp (OPRX) gains 6.7% institutional holder in Kennedy Capital - Stock Titan
Conferencia de resultados del segundo trimestre fiscal de 2026 de OptimizeRx (OPRX): Reitera previsiones mientras los ingresos caen un 30% - TradingKey
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - marketbeat.com
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com Nigeria
Citizens raises OptimizeRx stock price target on macro stability - Investing.com
Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX) Earnings Call zu Q2 des Geschäftsjahres 2026: Prognose bestätigt, während der Umsatz um 30 % sinkt - TradingKey
OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30% - TradingKey
Stifel cuts OptimizeRx stock price target on revenue headwinds By Investing.com - Investing.com Australia
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline - The Globe and Mail
OptimizeRx (OPRX) revenue falls 21% as margins and cash flow hold - Stock Titan
Stifel cuts OptimizeRx stock price target on revenue headwinds - Investing.com
OPTIMIZERx earnings beat by $0.06, revenue topped estimates - Investing.com Nigeria
OptimizeRx Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ... - Yahoo! Finance Canada
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth - Technology Magazine
OptimizeRx Q2 Earnings Call Highlights - MarketBeat
OPRX Looks 45.1% Undervalued on GF Value™ - GuruFocus
OptimizeRx Q2 adj. EPS beats estimate as sales fall 30% YoY - scanx.trade
Earnings call transcript: OptimizeRx beats Q2 2026 profit view as shares slip - Investing.com Australia
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Announces Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
OptimizeRx Latest Results: FY2026 sales guidance affirmed at $95M-$100M - scanx.trade
OptimizeRx names Andy D’Silva as CFO, Heather Favazza as CAO - Investing.com
OptimizeRx names Andy D’Silva as CFO, Heather Favazza as CAO By Investing.com - Investing.com India
OptimizeRx (OPRX) Q2 2026 revenue falls 30% but company reaffirms full-year outlook - Stock Titan
OptimizeRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
OptimizeRx CFO Ed Stelmakh Will Advise Through End of 2027 - Stock Titan
OptimizeRx Refinances Debt With $35M Facility, Pays Down $8.3M - Stock Titan
OptimizeRx Set to Report Q2 2026 Results With Analyst Targets Pointing to Over 80% Upside - finance.biggo.com
Earnings To Watch: OptimizeRx Corp (OPRX) Q2 2026 -- GF Value Sees 106% Upside - Yahoo Finance
OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OPRX News | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):